Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Telix securities between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options If you purchased or acquired F5 securities between October, 28 2024 and October 27, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eage ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Perrigo (PRGO) To Contact Him Directly To Discuss Their Options If you purchased or acquired Perrigo securities between February 27, 2023 and November 4, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- What’s Happening: ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Firefly (FLY) To Contact Him Directly To Discuss Their Options If you purchased or acquired Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about August 7, 2025 (the “IPO” or “Offering”); and/or (b) Firefly securities between August 7, 2025 and September 29, 2025 and would like to dis ...

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. for allegedly making false and misleading statements regarding its growth prospects during the Class Period from June 20, 2025, to September 24, 2025, leading to investor losses [5]. Allegation Details - The lawsuit claims that CarMax's management overstated the company's growth potential, attributing earlier growth in fiscal year 2026 to temporary factors related to customer behavior influenced by tariff speculation [5]. - It is alleged that the statements made by the defendants about CarMax's business operations and future prospects were materially false and misleading [5]. Financial Performance - On April 10, 2025, CarMax reported its fourth quarter and fiscal year 2025 results, which missed consensus estimates, leading to a stock price drop of $13.61, or 17%, closing at $66.45 per share [5]. - On September 25, 2025, CarMax disclosed significant declines in revenue and profit, including a 6.0% revenue decline, a 7.2% decline in total retail used vehicle revenues, and a 5.6% decline in total gross profit, resulting in a further stock price drop of $11.45, or 20.1%, closing at $45.60 per share [5].

Core Viewpoint - A class action lawsuit has been filed against DexCom, Inc. for allegedly making false and misleading statements regarding its products, particularly the G6 and G7 glucose monitoring devices, during the class period from July 26, 2024, to September 17, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York on behalf of all individuals and entities who purchased DexCom securities during the specified class period [2]. - Investors have until December 26, 2025, to apply to be appointed as lead plaintiff in the lawsuit [2]. Group 2: Allegations - The complaint alleges that DexCom made unauthorized design changes to the G6 and G7 devices that were not approved by the FDA, which compromised their reliability and posed health risks to users [3]. - It is claimed that the enhancements to the G7 were overstated, and the company downplayed the severity of issues related to the devices, leading to increased regulatory scrutiny and potential legal repercussions [3]. Group 3: Next Steps for Investors - Investors who suffered losses or have information regarding the claims are encouraged to contact the law firm for further details and assistance [4].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Baxter (BAX) To Contact Him Directly To Discuss Their Options If you purchased or Baxter common stock between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel ...

Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for allegedly misleading investors regarding its revenue outlook and sales performance during the class period from July 15, 2025, to August 14, 2025 [7]. Allegation Details - The lawsuit claims that Fly-E's management created a false impression of reliable information about the company's projected revenue and sales, while the actual demand for its electric vehicle products fell short [7]. - The complaint highlights that Fly-E's optimistic revenue goals were not met, and risks associated with lithium batteries, supply chain changes, and regulatory environments were downplayed [7]. - A significant 32% decrease in net revenue was reported, attributed to a decline in total units sold due to customer hesitance linked to lithium battery explosion incidents [7]. Financial Impact - Following the SEC filing on August 14, 2025, which disclosed the revenue decrease, Fly-E's stock price plummeted from $7.76 per share to $1.00 per share, marking an approximate 87% decline in just one day [7]. Next Steps - Investors who purchased Fly-E shares during the class period and suffered losses are encouraged to contact the law firm for more information and to discuss their legal rights [4].

Core Viewpoint - Johnson Fistel, PLLP is investigating FMC Corporation for potential breaches of fiduciary duties and violations of federal securities laws related to misleading statements and undisclosed adverse facts about the company's operations and prospects [1][2]. Group 1: Investigation Details - A class action complaint has been filed against FMC Corporation, alleging that the defendants made materially false and misleading statements and failed to disclose significant adverse facts about the company's business [2]. - Specific allegations include that FMC's channel management initiatives were not progressing as announced, the company avoided sales opportunities due to pricing pressure, and as a result, inventory levels in Latin America, Asia, Canada, and Eastern Europe became inflated [2]. Group 2: Shareholder Rights - Current stockholders who held FMC stock before November 16, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights regarding the investigation [3]. - Johnson Fistel, PLLP is a nationally recognized law firm that represents individual and institutional investors in shareholder derivative and securities class action lawsuits [3].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against CarMax, Inc. for possible violations of federal securities laws and unlawful business practices affecting stockholders [1][2]. Investigation Details - The investigation is focused on whether CarMax has engaged in practices that may have harmed investors, particularly in light of recent financial disclosures [1][2]. Financial Performance - On April 10, 2025, CarMax reported its fourth quarter and fiscal year 2025 results, missing consensus estimates and removing long-term revenue, unit sales, and market share goals due to macroeconomic factors, leading to a stock price drop of $13.61 (17%) to $66.45 per share [6]. - On September 25, 2025, CarMax disclosed significant year-over-year declines in revenue and profit, including a 6.0% revenue decline, a 7.2% decline in total retail used vehicle revenues, and a 5.6% decline in total gross profit, attributed to inventory adjustments and a $71.3 million increase in loan loss provisions, causing shares to fall by $11.45 (20.1%) to $45.60 per share [6].